logo
Prostate cancer scare in 2020 turned out to be 'false alarm' for singer Shaan

Prostate cancer scare in 2020 turned out to be 'false alarm' for singer Shaan

First Post25-04-2025

Sharing his experience at the launch of MenCan, an initiative of Urologic Oncology Disease Management Group (URO DMG), a unit of the Tata Memorial Centre (TMC) here, he also urged people to get medical tests done, saying health was of utmost importance. read more
Prostate cancer scare five years ago compelled noted playback singer Shaan to go for a check-up, which then confirmed that it was just a 'false alarm'.
Sharing his experience at the launch of MenCan, an initiative of Urologic Oncology Disease Management Group (URO DMG), a unit of the Tata Memorial Centre (TMC) here, he also urged people to get medical tests done, saying health was of utmost importance.
'I had a bit of a prostate scare in 2020, which I want to share with you. It almost led to a point where I was told by a few doctors that this could be prostate cancer, but it turned out it was a false alarm,' he told reporters.
STORY CONTINUES BELOW THIS AD
'Since then, I've been very, very careful in terms of getting my regular tests done. And that is something that I've done on a personal level, which again, when I share with my friends, it's very ticklish, it's very funny. Therefore, I realised that it's something that we need to, you know, create more awareness,' he said.
The voice behind countless hits such as 'Tanha Dil', 'Musu Musu Hasi', 'Jab Se Tere Naina' and 'Chand Sifarish', is now going to be the brand ambassador for MenCan initiative.
MenCan is a non-profit and non-commercial initiative that will address the challenges of prostate, penile and testicular cancers in men.
Shaan said there are certain taboos, stigmas and fear attached to the word cancer. 'The word itself, people don't want to use it, like it's almost like a scary word,' he said.
According to him, he quickly agreed to become the brand ambassador for MenCan because there is a taboo in the society about openly talking about prostate, testicular or penile cancer.
'You don't want to be forthcoming about it. Get yourself checked, get yourself administered because it feels kind of violated, scary. But we have to get over that because at the end of the day, your health, especially a man's health, is important. If a man is not in his best health, it's going to affect the family,' he said.
STORY CONTINUES BELOW THIS AD
'We need to talk about it. We need to bring awareness. And so I'm very happy that though I'm completely a lay person in the medical and scientific world, if I can be of any use, if I've been chosen to do this, I'll do my utmost to support MenCan,' he added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tata Memorial Centre's biggest tie up with Azim Premji's Wipro for noble cause of…, to set up…
Tata Memorial Centre's biggest tie up with Azim Premji's Wipro for noble cause of…, to set up…

India.com

timea day ago

  • India.com

Tata Memorial Centre's biggest tie up with Azim Premji's Wipro for noble cause of…, to set up…

Azim Premji- File image Tata Memorial Centre (TMC) has partnered with Wipro GE HealthCare Technologies Inc to set up a Cancer Research and Innovation Centre. This collaboration focuses on enhancing clinical research and academic initiatives through the formation of a 'Joint Working Group.' The group will identify key project areas and develop a collaborative roadmap for the next five years, TMC stated in its announcement. 'The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of daycare centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge,' Tata Memorial Hospital Director CS Pramesh stated. With Wipro GE HealthCare, TMC aims to enhance clinical research and promote academic engagement to transform personalised cancer care for improved outcomes cancer care, he added. 'With this partnership, we strengthen our commitment to connect every step of cancer care right from discovery, diagnosis to treatment, integrating advanced imaging technologies and AI-led solutions in the care continuum,' Wipro GE HealthCare South Asia President and CEO Chaitanya Sarawate said. In India, the estimated number of incidences of cancer cases was more than 14 lakhs in 2023, he added. As per industry estimates, around 100 out of every 1 lakh people in India are diagnosed with cancer, and a report from the Cancer Registry Program states the incidence of cancer cases is estimated to increase by 12.8 per cent in 2025 as compared to 2020. The Tata Memorial Hospital (TMH) was set up by the Sir Dorabji Tata Trust in 1941. It was placed under the control of the Indian government's Ministry of Health in 1957. In 1962, TMH began operating under the government's Department of Atomic Energy. In 1966, TMH was merged with the Indian Cancer Research Institute and renamed the Tata Memorial Centre (TMC). (With Inputs From PTI)

Tata Memorial Centre ties up with Wipro GE to set up cancer research centre
Tata Memorial Centre ties up with Wipro GE to set up cancer research centre

Business Standard

time6 days ago

  • Business Standard

Tata Memorial Centre ties up with Wipro GE to set up cancer research centre

Tata Memorial Centre has tied up with Wipro GE HealthCare Technologies Inc to establish a Cancer Research & Innovation Centre. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group' to determine key project areas and a collaboration roadmap for the next five years, Tata Memorial Centre (TMC) said in a statement. "The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of daycare centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge," Tata Memorial Hospital Director CS Pramesh stated. With Wipro GE HealthCare, TMC aims to enhance clinical research and promote academic engagement to transform personalised cancer care for improved outcomes cancer care, he added. "With this partnership, we strengthen our commitment to connect every step of cancer care right from discovery, diagnosis to treatment, integrating advanced imaging technologies and AI-led solutions in the care continuum," Wipro GE HealthCare South Asia President and CEO Chaitanya Sarawate said. In India, the estimated number of incidences of cancer cases was more than 14 lakhs in 2023, he added. As per industry estimates, around 100 out of every 1 lakh people in India are diagnosed with cancer, and a report from the Cancer Registry Program states the incidence of cancer cases is estimated to increase by 12.8 per cent in 2025 as compared to 2020. Mumbai-based Tata Memorial Centre is a comprehensive cancer care centre under the administrative control of the Department of Atomic Energy, Government of India. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Prostate cancer scare in 2020 turned out to be ‘false alarm' for singer Shaan
Prostate cancer scare in 2020 turned out to be ‘false alarm' for singer Shaan

The Print

time04-05-2025

  • The Print

Prostate cancer scare in 2020 turned out to be ‘false alarm' for singer Shaan

'I had a bit of a prostate scare in 2020, which I want to share with you. It almost led to a point where I was told by a few doctors that this could be prostate cancer, but it turned out it was a false alarm,' he told reporters. Sharing his experience at the launch of MenCan, an initiative of Urologic Oncology Disease Management Group (URO DMG), a unit of the Tata Memorial Centre (TMC) here, he also urged people to get medical tests done, saying health was of utmost importance. Mumbai, Apr 24 (PTI) Prostate cancer scare five years ago compelled noted playback singer Shaan to go for a check-up, which then confirmed that it was just a 'false alarm'. 'Since then, I've been very, very careful in terms of getting my regular tests done. And that is something that I've done on a personal level, which again, when I share with my friends, it's very ticklish, it's very funny. Therefore, I realised that it's something that we need to, you know, create more awareness,' he said. The voice behind countless hits such as 'Tanha Dil', 'Musu Musu Hasi', 'Jab Se Tere Naina' and 'Chand Sifarish', is now going to be the brand ambassador for MenCan initiative. MenCan is a non-profit and non-commercial initiative that will address the challenges of prostate, penile and testicular cancers in men. Shaan said there are certain taboos, stigmas and fear attached to the word cancer. 'The word itself, people don't want to use it, like it's almost like a scary word,' he said. According to him, he quickly agreed to become the brand ambassador for MenCan because there is a taboo in the society about openly talking about prostate, testicular or penile cancer. 'You don't want to be forthcoming about it. Get yourself checked, get yourself administered because it feels kind of violated, scary. But we have to get over that because at the end of the day, your health, especially a man's health, is important. If a man is not in his best health, it's going to affect the family,' he said. 'We need to talk about it. We need to bring awareness. And so I'm very happy that though I'm completely a lay person in the medical and scientific world, if I can be of any use, if I've been chosen to do this, I'll do my utmost to support MenCan,' he added. PTI SM NP This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store